Erschienen in:
11.05.2020 | Letter to the Editor
Differences in Breast Density Awareness, Knowledge, and Plans
verfasst von:
Nancy R. Kressin, PhD, Jolie B. Wormwood, PhD, Tracy A. Battaglia, MD, MPH, Christine M. Gunn, PhD
Erschienen in:
Journal of General Internal Medicine
|
Ausgabe 8/2020
Einloggen, um Zugang zu erhalten
Excerpt
Ms. Pushkin and Dr. Berg further emphasize a limitation we noted in our paper, “Differences in Breast Density Awareness, Knowledge and Plans on State Legislation Status and Sociodemographic Characteristics,” which is that states vary in the quality and quantity of information included in breast density notifications, and we did not have sufficient statistical power in our sample to examine the impact of such variations directly. We agree with Ms. Pushkin and Dr. Berg that it will be critically important for the Food and Drug Administration (FDA) to determine appropriate content requirements for the federally mandated notification as well as wording that is understandable to all women and leads to the desired outcomes: informing women about the risks of breast density and increased utilization of supplemental screening for women for whom it is appropriate. We have made this suggestion to the FDA and have provided them with the results of our study. …